Qube Research & Technologies (QRT)’s Immunome IMNM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.31M	Buy	439,186 +250,957	+133%	+$5.37M	0.01%	1330
2026 Q1	$4.12M	Buy	+188,229	New	+$4.19M	﹤0.01%	1766
2025 Q4	–	Sell	-25,217	Closed	-$295K	–	3859
2025 Q3	$295K	Buy	+25,217	New	+$251K	﹤0.01%	2854
2025 Q1	–	Sell	-107,794	Closed	-$1.14M	–	3669
2024 Q4	$1.14M	Sell	107,794 -51,016	-32%	-$616K	﹤0.01%	2116
2024 Q3	$2.32M	Sell	158,810 -234,592	-60%	-$3.33M	﹤0.01%	1708
2024 Q2	$4.76M	Sell	393,402 -137,060	-26%	-$2.14M	0.01%	1278
2024 Q1	$13.1M	Buy	530,462 +326,914	+161%	+$6.63M	0.02%	731
2023 Q4	$2.18M	Buy	203,548 +203,538	+2,035,380%	+$1.69M	﹤0.01%	1491
2023 Q3	$84	Buy	+10	New	+$73	﹤0.01%	3777

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMNM Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Immunome (IMNM) stake by 133% in Q2 2026, buying an estimated $5.37M and bringing the position to 439,186 shares worth $9.31M. The position accounts for 0.01% of the portfolio, ranked #1330.

Qube Research & Technologies (QRT) first reported a position in IMNM in Q3 2023 and has held it in 9 quarters since. The position peaked at $13.1M in Q1 2024. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

Qube Research & Technologies (QRT) held 439,186 shares of Immunome worth $9.31M as of Q2 2026.
Qube Research & Technologies (QRT) bought 250,957 Immunome shares in Q2 2026, an estimated $5.37M.
Immunome made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1330 holding.
Qube Research & Technologies (QRT) first reported a position in Immunome in Q3 2023 and has held it in 9 quarters since.
Qube Research & Technologies (QRT)'s Immunome position peaked at $13.1M in Q1 2024.
202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.